Get the Stockscreener App
5.98
1.87%
0.11
After Hours:
5.98
Profound Medical Corp stock is traded at $5.98, with a volume of 43,706.
It is up +1.87% in the last 24 hours and up +48.02% over the past month.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
See More
Previous Close:
$5.87
Open:
$5.91
24h Volume:
43,706
Relative Volume:
0.37
Market Cap:
$180.13M
Revenue:
$8.98M
Net Income/Loss:
$-31.39M
P/E Ratio:
-4.4627
EPS:
-1.34
Net Cash Flow:
$-24.83M
1W Performance:
+3.46%
1M Performance:
+48.02%
6M Performance:
+27.51%
1Y Performance:
-22.24%
1-Day Range:
$5.88
$6.2242
1-Week Range:
$5.65
$7.17
52-Week Range:
$3.76
$9.17
Profound Medical Corp Stock (PROF) Company Profile
Name
Profound Medical Corp
Sector
Industry
Phone
647-476-1350
Address
2400 SKYMARK AVENUE, UNIT 6, MISSISSAUGA, ON
Compare PROF with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PROF
Profound Medical Corp
|
5.98 | 176.41M | 8.98M | -31.39M | -24.83M | -1.34 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Profound Medical Corp Stock (PROF) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-23-24 | Initiated | Lake Street | Buy |
| Jul-16-24 | Upgrade | Stifel | Hold → Buy |
| Nov-28-23 | Initiated | Stifel | Hold |
| Aug-04-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Mar-21-23 | Downgrade | Jefferies | Buy → Hold |
| Sep-15-20 | Initiated | Jefferies | Buy |
View All
Profound Medical Corp Stock (PROF) Latest News
What technical charts say about Profound Medical Corp. stock2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Should you hold or exit Profound Medical Corp. nowCPI Data & Stock Market Timing Techniques - newser.com
Will Profound Medical Corp. stock benefit from AI adoptionWeekly Stock Recap & Scalable Portfolio Growth Ideas - newser.com
Profound Medical achieves record prelim revenue for third quarter - MSN
Technical analysis overview for Profound Medical Corp. stockTrade Entry Summary & Long-Term Safe Investment Ideas - newser.com
Technical signs of recovery in Profound Medical Corp.Market Activity Summary & Daily Technical Stock Forecast Reports - newser.com
(PRN) Market Performance Analysis (PRN:CA) - news.stocktradersdaily.com
What Fibonacci levels say about Profound Medical Corp. reboundJuly 2025 Recap & Accurate Buy Signal Notifications - newser.com
Using economic indicators to assess Profound Medical Corp. potentialJuly 2025 Volume & Low Drawdown Investment Ideas - newser.com
(PRN) Strategic Market Analysis (PRN:CA) - news.stocktradersdaily.com
Profound Medical Corp. stock trendline breakdown2025 Stock Rankings & AI Forecasted Stock Moves - newser.com
What risks investors should watch in Profound Medical Corp. stockWeekly Investment Recap & Technical Pattern Based Signals - newser.com
Profound Medical Corp. Hits Day High with Strong 10.71% Surge - Markets Mojo
Great week for Profound Medical Corp. (TSE:PRN) institutional investors after losing 17% over the previous year - simplywall.st
Profound Medical Achieves Record Preliminary Unaudited Revenue for the 2025 Third Quarter - Investing News Network
PROF Projects Significant Gross Margin Growth in Q3 2025 - GuruFocus
Profound Medical Reports Record Preliminary Q3 2025 Revenue - TipRanks
(PRN) Investment Analysis and Advice (PRN:CA) - news.stocktradersdaily.com
Combining machine learning predictions for Profound Medical Corp.Forecast Cut & Growth-Oriented Investment Plans - newser.com
What analysts say about Profound Medical Corp stockWeekly Market Snapshot & Free Stock Index Interpretations - earlytimes.in
3 Canadian Stocks That Could Turn $10,000 Into $100,000 - Yahoo
Profound Medical Announces First Quarter 2025 Financial Results - ADVFN
(PRN) Investment Strategy and Analysis (PRN:CA) - news.stocktradersdaily.com
What drives Profound Medical Corp stock priceTrade Execution Strategies & Minimal Investment Portfolio Growth - earlytimes.in
Raymond James Sticks to Their Buy Rating for Profound Medical (PRN) - The Globe and Mail
Profound Medical stock rating reiterated at Outperform by Raymond James By Investing.com - Investing.com Nigeria
Profound Medical: Expectations Worsen (NASDAQ:PROF) - Seeking Alpha
Profound Medical rises as TULSA procedure launched at Dallas Medical Center - MSN
Profound Medical stock rating reiterated at Outperform by Raymond James - Investing.com India
Can Profound Medical Deliver Over 70% Revenue Growth In 2025? - RTTNews
Profound Medical Expands TULSA Program in Texas, Enhancing Prostate Treatment Access - MSN
Profound Medical Corp. (TSE:PRN) is favoured by institutional owners who hold 51% of the company - Yahoo Finance
Profound Medical (PROF) Gains as Dallas Center Launches TULSA Pr - GuruFocus
Profound Medical Says First Tulsa Program for Prostate Treatment Launched in Texas; Shares Rise - MarketScreener
Profound Medical gains on TULSA launch in Dallas (PROF) - Seeking Alpha
Profound Medical Corp Stock (PROF) Financials Data
Revenue
Net Income
Cash Flow
EPS
Profound Medical Corp Stock (PROF) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Menawat Arun Swarup | CEO |
May 15 '25 |
Buy |
4.33 |
10,003 |
43,263 |
575,062 |
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):